Clinical Study to Evaluate the Safety and Effectiveness of the RxSight Light Adjustable Lens (LAL) in Subjects With Prior Corneal Refractive Surgery

NCT03660865 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

105

Enrollment

INDUSTRY

Sponsor class

Conditions

Aphakia
Cataract

Interventions

DEVICE: Light Adjustable lens (LAL) and Light Delivery Device (LDD)
DEVICE: Control IOL

Sponsor

RxSight, Inc.